Eyal Flom

Eyal Flom discloses dealings in InnoCan Pharma Corporation to SEDI. Over a trading history stretching from 25 September 2019 to 25 March 2024, the count stands at 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 28 March 2024, reports a transaction in InnoCan Pharma Corporation. Filings reach the SEDI feed a median of 7 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.